Current & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults
Program Overview
Explore the world of hereditary angioedema (HAE)—its underlying pathophysiology, the real-world burden it places on patients, and its profound impact on quality-of-life. This activity will guide you through the latest diagnostic criteria and treatment guidelines, spotlighting both long-term prophylactic strategies and on-demand therapies. Discover how to assess quality-of-life with validated tools, analyze compelling case studies, and stay ahead with data on emerging therapies.
Allergy/clinical immunology, primary care, and pediatric clinicians
Educational Objectives
Upon completion of this activity, participants should be better able to:
Explain the burden of hereditary angioedema (HAE)
Incorporate objective HAE quality-of-life assessment into clinical practice
Evaluate how emerging HAE on-demand and prophylactic therapies may improve patient outcomes
Create personalized HAE treatment plans
Activity Faculty
Marc A. Riedl, MD, MS
Professor, Medicine
HAE Community Endowed Chair Clinical Director, US HAEA Angioedema Center Clinical Service Chief and Training Program Director
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA